Home › Funds › Lightspeed Management Company, L.L.C. › OLMA
Lightspeed Management Company, L.L.C. position in OLMA
OLEMA PHARMACEUTICALS INC · Health Care
Lightspeed Management Company, L.L.C. reported holding 1,355,299 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$11.7M, representing 0.58% of its reported portfolio and ranking #6 among its reported holdings. Lightspeed Management Company, L.L.C. has disclosed OLMA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Lightspeed Management Company, L.L.C.'s OLMA position evolved
Lightspeed Management Company, L.L.C. first disclosed a stake in OLMA in Q4 2024 at 1,930,894 shares (US$11.3M). The position peaked in Q4 2025 at 1,930,894 shares, worth US$48.3M. Across 8 filings, Lightspeed Management Company, L.L.C. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,355,299 shares valued at US$11.7M. Notable position changes include a 30% trim in Q1 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.93M | $11.26M | New |
| Q1 2025 | 1.93M | $7.26M | Hold |
| Q2 2025 | 1.93M | $8.23M | Hold |
| Q3 2025 | 1.93M | $18.90M | Hold |
| Q4 2025 | 1.93M | $48.27M | Hold |
| Q1 2026 | 1.36M | $20.21M | Reduce |
| Q2 2026 | 1.36M | $16.95M | Hold |
| Q3 2026 | 1.36M | $11.71M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OLMA and 13F data
OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OLMA
- Paradigm Biocapital Advisors LP 8.67M sh · $108.47M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 7.09M sh · $88.64M · Q2 2026
- BVF INC/IL 5.30M sh · $66.25M · Q2 2026
- Siren, L.L.C. 4.86M sh · $41.96M · Q3 2026
- Logos Global Management LP 3.21M sh · $40.14M · Q2 2026
- Cormorant Asset Management, LP 2.15M sh · $26.90M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 1.20M sh · $15.01M · Q2 2026
- Defilade Capital Management, L.P. 924.76K sh · $11.57M · Q2 2026
More on Lightspeed Management Company, L.L.C.
FAQ
How long has Lightspeed Management Company, L.L.C. held OLMA?
Lightspeed Management Company, L.L.C. has disclosed OLMA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Lightspeed Management Company, L.L.C.'s current position in OLMA?
As of Q3 2026, Lightspeed Management Company, L.L.C. holds 1.36M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $11.71M, representing 0.58% of its reported portfolio and ranking #6.
Has Lightspeed Management Company, L.L.C. been buying or selling OLMA?
In the latest 13F filing (Q3 2026), Lightspeed Management Company, L.L.C. held unchanged its position in OLMA. The position peaked in Q4 2025 at 1.93M shares.
Which other funds hold OLMA?
Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.